CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers of Activity of Cabazitaxel in CRPC.

Clinical trial NCT03381326 · UNKNOWN

Trial details

NCT number: NCT03381326
Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Status: UNKNOWN
Study type: OBSERVATIONAL

Prostate Cancer Metastatic Cancer Castration-resistant Prostate Cancer Circulating Tumor Cells

Start date: 2014-12-15
Primary completion: 2019-10-01
Enrollment: 104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.